NovaBridge Biosciences (NBP) Inventory (2021 - 2023)

NovaBridge Biosciences (NBP) has reported Inventory for 3 consecutive years, with $718742.3 the latest figure, recorded in Q4 2023.

• Quarterly Inventory fell 84.49% year-over-year to $718742.3 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $718742.3 (down 84.49% YoY) and the FY2023 annual result came in at $729000.0, down 84.75% from the prior year.
• Inventory retreated to $718742.3 in Q4 2023 per NBP's latest filing, from $4.6 million in the prior quarter.
• Over the last five years, Inventory for NBP reached as high as $4.3 billion in Q4 2021 and fell as low as $718742.3 in Q4 2023.
• A 3-year average of $1.1 billion and a median of $7.6 million in 2022 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory slumped 99.89% — and 2023, when it sank 84.49%.
• Year by year, Inventory stood at $4.3 billion in 2021, then sank by 99.89% to $4.6 million in 2022, then plunged by 84.49% to $718742.3 in 2023.
• According to Business Quant data, Inventory over the past three periods registered $718742.3, $4.6 million, and $10.5 million for Q4 2023, Q4 2022, and Q2 2022 respectively.